Relationships between structure and interaction kinetics for HIV-1 protease inhibitors

被引:120
作者
Markgren, PO
Schaal, W
Hämäläinen, M
Karlén, A
Hallberg, A
Samuelsson, B
Danielson, UH [1 ]
机构
[1] Uppsala Univ, BMC, Dept Biochem, SE-75123 Uppsala, Sweden
[2] Uppsala Univ, BMC, Dept Organ Pharmaceut Chem, SE-75123 Uppsala, Sweden
[3] Biacore AB, SE-75450 Uppsala, Sweden
[4] Medivir AB, SE-14144 Huddinge, Sweden
关键词
D O I
10.1021/jm0208370
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The interaction between HIV-1 protease and 58 structurally diverse transition-state analogue inhibitors has been analyzed by a surface plasmon resonance based biosensor. Association and dissociation rate constants and affinities were determined and displayed as k(on)-k(off)-K-D maps. It was shown that different classes of inhibitors fall into distinct clusters in these maps. Significant changes in association and dissociation rates were found as a result of modifying the P1/P1' or P2/P2' side chains of a linear lead compound. Similarly, cyclic urea and cyclic sulfamide inhibitors displayed different kinetic features and the affinities of both classes of cyclic compounds were limited by fast dissociation rates. These results confirm that association and dissociation rates are important features of drug-target interactions and indicate that optimization of inhibitor efficacy may be guided by aiming for high association and low dissociation rates rather than high affinity alone. The present approach thus provides a new tool for structure-interaction kinetic analysis and drug discovery.
引用
收藏
页码:5430 / 5439
页数:10
相关论文
共 47 条
  • [31] Synthesis of enantiomerically pure cis and trans 2-aminocyclopentanecarboxylic acids. Use of proline replacements in potential HIV-protease inhibitors.
    Noteberg, D
    Branalt, J
    Kvarnstrom, I
    Classon, B
    Samuelsson, B
    Nillroth, U
    Danielson, H
    Karlen, A
    Hallberg, A
    [J]. TETRAHEDRON, 1997, 53 (23) : 7975 - 7984
  • [32] Solid phase assisted synthesis of HIV-1 protease inhibitors.: Expedient entry to unsymmetrical substitution of a C2 symmetric template
    Oscarsson, K
    Classon, B
    Kvarnström, I
    Hallberg, A
    Samuelsson, B
    [J]. CANADIAN JOURNAL OF CHEMISTRY, 2000, 78 (06) : 829 - 837
  • [33] PEARLMAN RS, LAB MOL GRAPHICS THE
  • [34] Effectors of HIV-1 protease peptidolytic activity
    Porter, DJT
    Hanlon, MH
    Carter, LH
    Danger, DP
    Furfine, ES
    [J]. BIOCHEMISTRY, 2001, 40 (37) : 11131 - 11139
  • [35] Advances in surface plasmon resonance biosensor analysis
    Rich, RL
    Myszka, DG
    [J]. CURRENT OPINION IN BIOTECHNOLOGY, 2000, 11 (01) : 54 - 61
  • [36] HIV chemotherapy
    Richman, DD
    [J]. NATURE, 2001, 410 (6831) : 995 - 1001
  • [37] Synthesis and comparative molecular field analysis (CoMFA) of symmetric and nonsymmetric cyclic sulfamide HIV-1 protease inhibitors
    Schaal, W
    Karlsson, A
    Ahlsén, G
    Lindberg, J
    Andersson, HO
    Danielson, UH
    Classon, B
    Unge, T
    Samuelsson, B
    Hultén, J
    Hallberg, A
    Karlén, A
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (02) : 155 - 169
  • [38] Conformational stability and catalytic activity of HIV-1 protease are both enhanced at high salt concentration
    Szeltner, Z
    Polgar, L
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) : 5458 - 5463
  • [39] Thaisrivongs S, 1999, BIOPOLYMERS, V51, P51
  • [40] Targeting the HIV-protease in AIDS therapy: a current clinical perspective
    Tomasselli, AG
    Heinrikson, RL
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2): : 189 - 214